Control of Rhodopsin Activity in Vision

Total Page:16

File Type:pdf, Size:1020Kb

Control of Rhodopsin Activity in Vision Control of rhodopsin DENIS A. BAYLOR, MARIE E. BURNS activity in vision Abstract high concentration in the cytoplasm in darkness and that binds to cationic channels in the Although rhodopsin's role in activating the surface membrane, holding them open. phototransduction cascade is well known, the Hydrolysis of cGMP allows the channels to processes that deactivate rhodopsin, and thus close, interrupting an inward current of sodium, the rest of the cascade, are less well calcium and magnesium ions and producing a understood. At least three proteins appear to hyperpolarisation of the membrane. The play a role: rhodopsin kinase, arrestin and hyperpolarisation reduces the rate at which recoverin. Here we review recent physiological neurotransmitter is released from the synaptic studies of the molecular mechanisms of terminal of the rod. rhodopsin deactivation. The approach was to The purpose of this paper is to review recent monitor the light responses of individual work on the important but still poorly mouse rods in which rhodopsin was altered or understood mechanisms that terminate the arrestin was deleted by transgenic techniques. light-evoked catalytic activity of rhodopsin. Removal of rhodopsin's carboxy-terminal These mechanisms, which fix the intensity and residues which contain phosphorylation sites duration of the activation of the transduction implicated in deactivation, prolonged the flash cascade, need to satisfy strong functional response 20-fold and caused it to become constraints. Rhodopsin activity must be highly variable. In rods that did not express arrestin the flash response recovered partially, terminated rapidly so that an absorbed photon but final recovery was slowed over lOO-fold. can be registered without contamination by These results are consistent with the notion after-effects of previous absorptions, yet it must that phosphorylation initiates rhodopsin last long enough to give an easily detectable deactivation and that arrestin binding electrical response. Furthermore, activity should completes the process. The stationary night be shut off in a stereotyped fashion so that each blindness of Oguchi disease, associated with absorbed photon is encoded identically, null mutations in the genes for arrestin or allowing the brain to make an accurate rhodopsin kinase, presumably results from assessment of the number and timing of photon impaired rhodopsin deactivation, like that absorptions. Finally, shut-off should be revealed by the experiments on transgenic complete and irreversible, since escape of animals. recently deactivated rhodopsin molecules to the active state may falsely signal photon absorptions, generating masking noise that Key words Arrestin, Kinase, Night blindness, Rhodopsin, Rod, Transgenic interferes with normal vision. Given these constraints, it is perhaps not surprising that the deactivation of rhodopsin Rhodopsin's role in vision is well known; upon seems to involve fairly complex mechanisms. absorption of light it activates a G-protein Our current understanding of the process, cascade that generates an electrical response at drawn largely from in vitro biochemical the surface membrane of the retinal rod cell. DA Baylor � experiments, is summarised in Fig. 2. At least M.E. Burns This response encodes the absorption of single three proteins seem to play key roles: rhodopsin Department of photons, and upon transfer through the visual kinase, arrestin! p44 and recoverin. Neurobiology pathway it ultimately elicits visual sensations. Photo activated rhodopsin can be rapidly Stanford University School Rhodopsin's role in signal generation within the phosphorylated at multiple serine and of Medicine Stanford rod is diagrammed in Fig. l. threonine residues near its carboxy(C)­ CA94305, USA Photoisomerised rhodopsin catalyses GTP! terminus.! This phosphorylation is catalysed by Tel: +1 (650) 723-6510 GDP exchange on the G-protein transducin, a rhodopsin kinase.2 Phosphorylation of Fax: + 1 (650) 725-3958 single rhodopsin producing hundreds of copies rhodopsin reduces its ability to activate of activated transducin (T GTP) within a fraction transducin and permits the binding of the This research was supported by Grant EY05750 from the of a second. T GTP activates a cyclic GMP soluble capping protein arrestin, which further National Eye Institute, the phosphodiesterase (PDE). This enzyme quenches rhodopsin's activity?A Recoverin, a Ruth and Milton Steinbach hydrolyses cyclic GMP (cGMP), a diffusible calcium-binding protein, can inhibit rhodopsin Fund, and the McKnight internal messenger that is present at relatively phosphorylation in vitro5 by binding to Foundation Eye (1998) 12, 521-525 © 1998 Royal College of Ophthalmologists 521 phototransduction in rods of transgenic mice in which the primary structure of rhodopsin was altered or one or both genes for arrestin was deleted. The molecular biology was performed in the laboratory of Professor Melvin Simon at the California Institute of Technology, using methods that have been described elsewhere.ll.12 Rh T POE Immunoblot analysis was used to compare the levels of phototransduction proteins in transgenic and control animals. The expression of truncated rhodopsin and the Na+ absence of arrestin did not appear to affect the relative expression levels of other transduction proteins, Ca++ although rearing the animals in the light caused shortening of the outer segments in some transgenics. Mg++ Phototransduction in single rods was monitored by using a suction electrode to record the reduction in inward current that resulted from flashes of 500 nm light (Fig. 3). This method allows one to observe the rod's response to a single photon. 13 Results and discussion Role of phosphorylation in deactivation of rhodopsin Previous studies demonstrated that supplying A TP to truncated, internally dialysed salamander rod outer Fig. 1. Amplifying cascade of phototransduction in the retinal rod. In segments reduced the amplitude and duration of the the dark, sodium, calcium and magnesium ions flow into the rod outer flash response, suggesting a role for phosphorylation in segment through channels held open by cyclic GMP (cGMP). Upon deactivation of the cascade.14 The C-terminus of excitation by light, rhodopsin (Rh) in the disc membrane activates the rhodopsin contains multiple serine and threonine G-protein transducin (T), which in turn activates cGMP phospho­ diesterase (POE). POE hydrolyses cGMP, causing intracellular cGMP residues that can be phosphorylated after levels to drop and channels on the surface membrane to close. The photoisomerisation occurs. Three of these sites (5334, decrease in the inward current hyperpolarises the rod, causing a 5338, 5343) have been implicated as the preferred sites reduced rate of neurotransmitter release from the synaptic terminal. for rhodopsin kinase.IS Pharmacological inhibition of rhodopsin kinase in isolated rod outer segments rhodopsin kinase under conditions of high calcium interfered with the recovery of light reponses, suggesting concentration.6.7 When the calcium level inside the rod that phosphorylation of rhodopsin by rhodopsin kinase drops during the response to light, inhibition of the reduces its catalytic activity.4 To test whether kinase by recoverin should be removed, causing phosphorylation of rhodopsin at its C-terminus is rhodopsin deactivation to proceed more rapidly, thus producing the decreased sensitivity characteristic of light adaptation. An alternative pathway for rhodopsin Rh deactivation may be provided by a truncated splice variant of arrestin, p44, which can bind to hvi nATP nADP * unphosphorylated rhodopsin and strongly inhibit its ** � Rh -! .. Rh nP activity.8 Thus, p44 may provide an important backup Rh Kinase mechanism for phosphorylation-independent shut-off of rhodopsin. Failure of proper rhodopsin deactivation is Rec·Ca presumably the cause of the functional defect in Oguchi ''''''''''"1 te r"""'" disease, a recessively inherited form of stationary night Rh-p44 blindness that is linked to homozygous deletions or �2ca RhnP-Arr Rec missense mutations in the arrestin9 or rhodopsin kinaselO (inactive) (inactive) genes. How is rhodopsin deactivated under physiological Fig. 2. Rhodopsin deactivation scheme derived from biochemical conditions? Do rhodopsin kinase and arrestin indeed experiments. After absorption of a photon (hv), rhodopsin !Rh) is function sequentially, as in the scheme of Fig. 2? What activated (Rh**) until it is phosphorylated by rhodopsin kinllse !Rh are the individual contributions of phosphorylation and kinase), which reduces its catalytic activity (Rh*). In the presence of arrestin binding to deactivation, and what happens if calcium, rhodopsin kinase is inhibited by calcium-bound recoverin (Rec-ea), which makes rhodopsin deactivation calcium-sfnsitil'f. either process fails? Which site(s) on rhodopsin are Arrestin binds to phosphorylated rhodopsin (RhI1P*),jurther qllenching phosphorylated? The purpose of this paper is to review its activity. A splice variant of arrestin (p44) can bind to Ilnd inhibit recent physiological work that has examined these the activity of unphosphorylated rhodopsin, providing an altemative questions. The approach was to observe deactivation pathway that is independent of phosphorylation. 522 10% of cases the single photon response was anomalous, with a rectangular waveform, an amplitude 2 times larger than normal, and a very prolonged time course. In 90% of the trials the single photon response was entirely normal. The relative numbers
Recommended publications
  • Shedding New Light on the Generation of the Visual Chromophore PERSPECTIVE Krzysztof Palczewskia,B,C,1 and Philip D
    PERSPECTIVE Shedding new light on the generation of the visual chromophore PERSPECTIVE Krzysztof Palczewskia,b,c,1 and Philip D. Kiserb,d Edited by Jeremy Nathans, Johns Hopkins University School of Medicine, Baltimore, MD, and approved July 9, 2020 (received for review May 16, 2020) The visual phototransduction cascade begins with a cis–trans photoisomerization of a retinylidene chro- mophore associated with the visual pigments of rod and cone photoreceptors. Visual opsins release their all-trans-retinal chromophore following photoactivation, which necessitates the existence of pathways that produce 11-cis-retinal for continued formation of visual pigments and sustained vision. Proteins in the retinal pigment epithelium (RPE), a cell layer adjacent to the photoreceptor outer segments, form the well- established “dark” regeneration pathway known as the classical visual cycle. This pathway is sufficient to maintain continuous rod function and support cone photoreceptors as well although its throughput has to be augmented by additional mechanism(s) to maintain pigment levels in the face of high rates of photon capture. Recent studies indicate that the classical visual cycle works together with light-dependent pro- cesses in both the RPE and neural retina to ensure adequate 11-cis-retinal production under natural illu- minances that can span ten orders of magnitude. Further elucidation of the interplay between these complementary systems is fundamental to understanding how cone-mediated vision is sustained in vivo. Here, we describe recent
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Early B-Cell Factors Are Required for Specifying Multiple Retinal Cell Types and Subtypes from Postmitotic Precursors
    11902 • The Journal of Neuroscience, September 8, 2010 • 30(36):11902–11916 Development/Plasticity/Repair Early B-Cell Factors Are Required for Specifying Multiple Retinal Cell Types and Subtypes from Postmitotic Precursors Kangxin Jin,1,2 Haisong Jiang,1,2 Zeqian Mo,3 and Mengqing Xiang1,2 1Center for Advanced Biotechnology and Medicine and Department of Pediatrics, 2Graduate Program in Molecular Genetics, Microbiology and Immunology, and 3Department of Cell Biology and Neuroscience, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854 The establishment of functional retinal circuits in the mammalian retina depends critically on the proper generation and assembly of six classes of neurons, five of which consist of two or more subtypes that differ in morphologies, physiological properties, and/or sublaminar positions. How these diverse neuronal types and subtypes arise during retinogenesis still remains largely to be defined at the molecular level. Here we show that all four family members of the early B-cell factor (Ebf) helix-loop-helix transcription factors are similarly expressedduringmouseretinogenesisinseveralneuronaltypesandsubtypesincludingganglion,amacrine,bipolar,andhorizontalcells, and that their expression in ganglion cells depends on the ganglion cell specification factor Brn3b. Misexpressed Ebfs bias retinal precursors toward the fates of non-AII glycinergic amacrine, type 2 OFF-cone bipolar and horizontal cells, whereas a dominant-negative Ebf suppresses the differentiation of these cells as well as ganglion cells. Reducing Ebf1 expression by RNA interference (RNAi) leads to an inhibitory effect similar to that of the dominant-negative Ebf, effectively neutralizes the promotive effect of wild-type Ebf1, but has no impact on the promotive effect of an RNAi-resistant Ebf1.
    [Show full text]
  • Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
    Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen,
    [Show full text]
  • Synergetic Effect of Recoverin and Calmodulin on Regulation of Rhodopsin Kinase
    Thomas Jefferson University Jefferson Digital Commons Department of Biochemistry and Molecular Department of Biochemistry and Molecular Biology Faculty Papers Biology 1-1-2012 Synergetic effect of recoverin and calmodulin on regulation of rhodopsin kinase. Ilya I Grigoriev Lomonosov Moscow State University Ivan I Senin Lomonosov Moscow State University Natalya K Tikhomirova Lomonosov Moscow State University Konstantin E Komolov Lomonosov Moscow State University; University of Oldenburg, Oldenburg, Germany; Department of FBiochemistrollow this andy and additional Molecular works Biology at: ,https:/ Thomas/jdc.jeff Jeffersonerson.edu/bmpfp University Ser geiPar tE of P theermy Medicalakov Biochemistry Commons, and the Medical Molecular Biology Commons LetInstitute us for knowBiological Instrumentationhow access of the tRussiano this Academy document of Sciences benefits ouy RecommendedSee next page for Citation additional authors Grigoriev, Ilya I; Senin, Ivan I; Tikhomirova, Natalya K; Komolov, Konstantin E; Permyakov, Sergei E; Zernii, Evgeni Yu; Koch, Karl-Wilhelm; and Philippov, Pavel P, "Synergetic effect of recoverin and calmodulin on regulation of rhodopsin kinase." (2012). Department of Biochemistry and Molecular Biology Faculty Papers. Paper 36. https://jdc.jefferson.edu/bmpfp/36 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Department of Biochemistry and Molecular Biology Faculty Papers by an authorized administrator of the Jefferson Digital Commons.
    [Show full text]
  • Absence of S100A4 in the Mouse Lens Induces an Aberrant Retina-Specific Differentiation Program and Cataract
    www.nature.com/scientificreports OPEN Absence of S100A4 in the mouse lens induces an aberrant retina‑specifc diferentiation program and cataract Rupalatha Maddala1*, Junyuan Gao2, Richard T. Mathias2, Tylor R. Lewis1, Vadim Y. Arshavsky1,3, Adriana Levine4, Jonathan M. Backer4,5, Anne R. Bresnick4 & Ponugoti V. Rao1,3* S100A4, a member of the S100 family of multifunctional calcium‑binding proteins, participates in several physiological and pathological processes. In this study, we demonstrate that S100A4 expression is robustly induced in diferentiating fber cells of the ocular lens and that S100A4 (−/−) knockout mice develop late‑onset cortical cataracts. Transcriptome profling of lenses from S100A4 (−/−) mice revealed a robust increase in the expression of multiple photoreceptor‑ and Müller glia‑specifc genes, as well as the olfactory sensory neuron‑specifc gene, S100A5. This aberrant transcriptional profle is characterized by corresponding increases in the levels of proteins encoded by the aberrantly upregulated genes. Ingenuity pathway network and curated pathway analyses of diferentially expressed genes in S100A4 (−/−) lenses identifed Crx and Nrl transcription factors as the most signifcant upstream regulators, and revealed that many of the upregulated genes possess promoters containing a high‑density of CpG islands bearing trimethylation marks at histone H3K27 and/or H3K4, respectively. In support of this fnding, we further documented that S100A4 (−/−) knockout lenses have altered levels of trimethylated H3K27 and H3K4. Taken together,
    [Show full text]
  • Miami University – the Graduate School
    MIAMI UNIVERSITY – THE GRADUATE SCHOOL CERTIFICATE FOR APPROVING THE DISSERTATION We hereby approve the Dissertation Of Elvis K. Tiburu Candidate for the Degree: Doctor of Philosophy Dr. Gary A. Lorigan, Director Dr. Christopher A. Makaroff, Reader Dr. Robert E. Minto, Reader Dr. Richard T. Taylor, Reader Dr. David G. Pennock Graduate School Representative ABSTRACT DEVELOPMENT OF NEW METHODS FOR THE ALIGNMENT OF LONGER CHAIN PHOSPHOLIPIDS IN BICELLES AND SOLID-STATE NMR STUDIES OF PHOSPHOLAMBAN by Elvis K. Tiburu Magnetically aligned phospholipid bilayers or bicelles are model systems that mimic biological membranes for magnetic resonance studies. A long chain phospholipid bilayer system that spontaneously aligns in a static magnetic field was characterized utilizing solid-state NMR spectroscopy. The oriented membrane system was composed of a mixture of the bilayer-forming phospholipid palmitoylstearoylphosphatidylcholine (PSPC) and the short-chain phospholipid dihexanoylphosphatidylcholine (DHPC) that breaks up the extended bilayers into bilayered micelles or bicelles that are highly hydrated. Traditionally, the shorter 14-carbon chain phospholipid dimyristoyl- phosphatidylcholine (DMPC) has been utilized as the bilayer-forming phospholipid in bicelle studies. The effect of cholesterol in bicelles containing chain perdeuterated 2 DMPC, a partially deuterated (a-[2,2,3,4,4,6- H6]) cholesterol, and stearic acid-d35 has been reported as a function of temperature using 2H solid-state NMR spectroscopy. The order parameters of the labeled probes were calculated and compared with values obtained from unoriented samples in the literature. In addition, 2H solid-state NMR spectroscopy was used to investigate the orientation and side chain dynamics of specific- labeled methyl groups of leucines in PLB in unoriented as well as in magnetically and mechanically aligned phospholipids bilayers.
    [Show full text]
  • Rhodopsin Kinase Activity Modulates the Amplitude of the Visual Response in Drosophila
    Rhodopsin kinase activity modulates the amplitude of the visual response in Drosophila Seung-Jae Lee*, Hong Xu, and Craig Montell† Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD 21205 Edited by Robert J. Lefkowitz, Duke University Medical Center, Durham, NC, and approved June 30, 2004 (received for review March 29, 2004) A feature shared between Drosophila rhodopsin and nearly all tractability of fly genetics (14). As in mammals, light-activated other G protein-coupled receptors is agonist-dependent protein rhodopsin is phosphorylated and interacts with a protein, arres- phosphorylation. Despite extensive analyses of Drosophila photo- tin, which facilitates deactivation of the receptor. However, transduction, the identity and function of the rhodopsin kinase unlike mammalian phototransduction, light activation in Dro- (RK) have been elusive. Here, we provide evidence that G protein- sophila is coupled to stimulation of phospholipase C rather than coupled receptor kinase 1 (GPRK1), which is most similar to the a cGMP-phosphodiesterase. ␤-adrenergic receptor kinases, G protein-coupled receptor kinase 2 Two Drosophila genes encoding putative GRKs (GPRK1 and (GRK2) and GRK3, is the fly RK. We show that GPRK1 is enriched in GPRK2) were isolated more than a decade ago (15), but were photoreceptor cells, associates with the major Drosophila rhodop- dismissed as candidate RKs due in part to their much greater sin, Rh1, and phosphorylates the receptor. As is the case with similarity to mammalian nonvisual GRKs than to mammalian mammalian GRK2 and GRK3, Drosophila GPRK1 includes a C- RKs. Subsequent analysis of GPRK2 demonstrated that it is terminal pleckstrin homology domain, which binds to phosphoi- expressed in the ovaries and required for egg morphogenesis nositides and the G␤␥ subunit.
    [Show full text]
  • Biochemical Journal
    www.biochemj.org Biochem. J. (2007) 405, 199–221 (Printed in Great Britain) doi:10.1042/BJ20070255 199 REVIEW ARTICLE Structures and metal-ion-binding properties of the Ca2+-binding helix–loop–helix EF-hand motifs Jessica L. GIFFORD*, Michael P. WALSH† and Hans J. VOGEL*1 *Structural Biology Research Group, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada T2N 1N4, and †Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1 The ‘EF-hand’ Ca2+-binding motif plays an essential role in interaction site or structure formation from a molten-globule eukaryotic cellular signalling, and the proteins containing this apo state. EF-hand proteins exhibit various sensitivities to Ca2+, motif constitute a large and functionally diverse family. The EF- reflecting the intrinsic binding ability of the EF-hand as well as hand is defined by its helix–loop–helix secondary structure as the degree of co-operativity in Ca2+ binding to paired EF-hands. well as the ligands presented by the loop to bind the Ca2+ ion. The Two additional factors can influence the ability of an EF-hand identity of these ligands is semi-conserved in the most common to bind Ca2+: selectivity over Mg2+ (a cation with very similar (the ‘canonical’) EF-hand; however, several non-canonical EF- chemical properties to Ca2+ and with a cytoplasmic concentration hands exist that bind Ca2+ by a different co-ordination mechanism. several orders of magnitude higher) and interaction with a protein EF-hands tend to occur in pairs, which form a discrete domain so target.
    [Show full text]
  • Balancing the Photoreceptor Proteome: Proteostasis Network Therapeutics for Inherited Retinal Disease
    G C A T T A C G G C A T genes Review Balancing the Photoreceptor Proteome: Proteostasis Network Therapeutics for Inherited Retinal Disease Siebren Faber and Ronald Roepman * Department of Human Genetics and Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands * Correspondence: [email protected] Received: 10 June 2019; Accepted: 16 July 2019; Published: 24 July 2019 Abstract: The light sensing outer segments of photoreceptors (PRs) are renewed every ten days due to their high photoactivity, especially of the cones during daytime vision. This demands a tremendous amount of energy, as well as a high turnover of their main biosynthetic compounds, membranes, and proteins. Therefore, a refined proteostasis network (PN), regulating the protein balance, is crucial for PR viability. In many inherited retinal diseases (IRDs) this balance is disrupted leading to protein accumulation in the inner segment and eventually the death of PRs. Various studies have been focusing on therapeutically targeting the different branches of the PR PN to restore the protein balance and ultimately to treat inherited blindness. This review first describes the different branches of the PN in detail. Subsequently, insights are provided on how therapeutic compounds directed against the different PN branches might slow down or even arrest the appalling, progressive blinding conditions. These insights are supported by findings of PN modulators in other research disciplines. Keywords: protein trafficking; protein folding; protein degradation; chaperones; chaperonins; heat shock response; unfolded protein response; autophagy; therapy 1. Introduction The rod and cone photoreceptor (PR) cells are the most abundant cell types in the human retina, with ~6.4 million cones and up to 125 million rods per adult retina [1].
    [Show full text]
  • Dimerization of Neuronal Calcium Sensor Proteins
    UC Davis UC Davis Previously Published Works Title Dimerization of Neuronal Calcium Sensor Proteins. Permalink https://escholarship.org/uc/item/8426s2jv Author Ames, James B Publication Date 2018 DOI 10.3389/fnmol.2018.00397 Peer reviewed eScholarship.org Powered by the California Digital Library University of California REVIEW published: 02 November 2018 doi: 10.3389/fnmol.2018.00397 Dimerization of Neuronal Calcium Sensor Proteins James B. Ames* Department of Chemistry, University of California, Davis, Davis, CA, United States 2 Neuronal calcium sensor (NCS) proteins are EF-hand containing Ca C binding proteins that regulate sensory signal transduction. Many NCS proteins (recoverin, GCAPs, neurocalcin and visinin-like protein 1 (VILIP1)) form functional dimers under physiological conditions. The dimeric NCS proteins have similar amino acid sequences (50% homology) but each bind to and regulate very different physiological targets. Retinal 2 recoverin binds to rhodopsin kinase and promotes Ca C-dependent desensitization of light-excited rhodopsin during visual phototransduction. The guanylyl cyclase activating proteins (GCAP1–5) each bind and activate retinal guanylyl cyclases (RetGCs) in light- adapted photoreceptors. VILIP1 binds to membrane targets that modulate neuronal secretion. Here, I review atomic-level structures of dimeric forms of recoverin, GCAPs and VILIP1. The distinct dimeric structures in each case suggest that NCS dimerization may play a role in modulating specific target recognition. The dimerization of recoverin 2 2 and VILIP1 is Ca C-dependent and enhances their membrane-targeting Ca C-myristoyl switch function. The dimerization of GCAP1 and GCAP2 facilitate their binding to dimeric 2 RetGCs and may allosterically control the Ca C-dependent activation of RetGCs.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0158968 A1 Panitch Et Al
    US 20100158968A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0158968 A1 Panitch et al. (43) Pub. Date: Jun. 24, 2010 (54) CELL-PERMEANT PEPTIDE-BASED Publication Classification INHIBITOR OF KINASES (51) Int. Cl. (76) Inventors: Alyssa Panitch, West Lafayette, IN st e8 CR (US); Brandon Seal, West ( .01) Lafayette, IN (US) A638/10 (2006.01) s A638/16 (2006.01) Correspondence Address: A6IP 43/00 (2006.01) GREENBERG TRAURIG, LLP (52) U.S. Cl. ................ 424/422:514/15: 514/13: 514/14 200 PARKAVE., P.O. BOX 677 FLORHAMPARK, NJ 07932 (US) (57) ABSTRACT The described invention provides kinase inhibiting composi (21) Appl. No.: 12/634,476 tions containing a therapeutic amount of a therapeutic inhibi (22) Filed: Dec. 9, 2009 torpeptide that inhibits at least one kinase enzyme, methods e 19 for treating an inflammatory disorder whose pathophysiology comprises inflammatory cytokine expression, and methods Related U.S. Application Data for treating an inflammatory disorder whose pathophysiology (60) Provisional application No. 61/121,396, filed on Dec. comprises inflammatory cytokine expression using the kinase 10, 2008. inhibiting compositions. 20 { ki> | 0: & c s - --- 33- x: SE PEPELE, ics 1.-- E- X K. AAA 22.9 --- KKK. Y.A., 3.2; C. -r { AAEASA. A. E. i : A X AAAAAAA; ; ; ; :-n. 4:-: is SEEKESAN.ARESA, 3523 -- -- Yili.A.R.AKA: 5,342 3. {{RCE: Rix i: Patent Application Publication US 2010/0158968A1 & ******** NO s ***** · Patent Application Publication Jun. 24, 2010 Sheet 2 of 11 US 2010/0158968A1 it, O Peptide: Cso: g E 100 WRRKAWRRKANRO, GWAA.
    [Show full text]